Medley Capital Corporation Announces March 31, 2020 Financial Results
NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) today announced financial […]
Con Edison Announces Change to Location of Annual Meeting of Stockholders to a Virtual-Only Format
NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Consolidated Edison, Inc. (Con Edison) (NYSE: ED) will hold its annual meeting […]
Merus Announces Financial Results for the First Quarter and Provides Business Update
MCLA-128, zenocutuzumab, Phase 1/2 eNRGy trial remains on trackMCLA-117 program update to be presented at upcoming medical meetingAnand Mehra, M.D. […]
Advanced Emissions Solutions Reports First Quarter 2020 Results
Distributions from Tinuum total $17.1 million; Prioritizing cash and liquidity to navigate pandemic related business impactsGREENWOOD VILLAGE, Colo., May 11, […]
Information Services Group Announces First-Quarter 2020 Results
Reports first-quarter revenues of $64 million; net loss of $1 million; GAAP EPS loss of $0.03; adjusted EPS of $0.02; […]
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative […]
Fortress Biotech Reports Record First Quarter 2020 Financial Results and Recent Corporate Highlights
First quarter 2020 product revenue increased 95% year-over-year to $11.9 millionNDA for IV tramadol accepted for review by FDA; assigned […]
Core-Mark to Webcast Presentation from 2020 BMO Farm to Market Conference
WESTLAKE, Texas, May 11, 2020 (GLOBE NEWSWIRE) — Core-Mark Holding Company, Inc. (NASDAQ: CORE), one of the largest marketers of […]
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
REMINDER: Genocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors
CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will […]
